Literature DB >> 28389877

Results and recurrence of pigmented villonodular synovitis of the ankle: does diffuse PVNS with extra-articular extension tend to recur more often?

QinWei Guo1, WeiLi Shi1, Chen Jiao1, Xing Xie1, Dong Jiang1, YueLin Hu2.   

Abstract

PURPOSE: The aim of this study was to provide the outcomes and to analyze the recurrence of Pigmented Villonodular Synovitis (PVNS) of the ankle joint treated by surgical synovectomy.
METHODS: Thirty-one PVNS cases of the ankle, including 5 localized PVNS cases and 26 diffuse PVNS cases, were treated in our institute between 2004 and 2015. The median age was 35 (range 18-63) years. The 5 localized PVNS cases were treated with partial synovectomy (group I); 10 diffuse PVNS cases limited to intra-articular synovium received arthroscopic comprehensive synovectomy (group II); and 16 cases with diffuse PVNS spreading to extra-articular tendon sheaths underwent combined arthroscopic and open synovectomy (group III). Adjuvant radiotherapy was provided in groups II and III. The American Orthopaedic Foot and Ankle Society (AOFAS) score and subjective grading of procedure were used to evaluate the results.
RESULTS: Twenty-seven patients were followed with a median of 54 (range 15-108) months. In the three groups, the average AOFAS score improved from 75 (in all three groups) points preoperatively to 100 (group I), 97 (group II), and 90 points (group III) postoperatively. The rate of good-to-excellent result was 100% in group I and II and 73.3% in group III. Only in group III, recurrence occurred in five cases.
CONCLUSIONS: Diffuse PVNS of the ankle can be successfully managed with surgical synovectomy and adjuvant radiotherapy. Radiotherapy is not needed for localized PVNS. The recurrence rate in PVNS patients with extra-articular extension is higher. LEVEL OF EVIDENCE: IV.

Entities:  

Keywords:  Ankle; Arthroscopy; Pigmented villonodular synovitis; Recurrence; Synovectomy

Mesh:

Year:  2017        PMID: 28389877     DOI: 10.1007/s00167-017-4488-8

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  21 in total

Review 1.  Result of arthroscopic treatment of pigmented villonodular synovitis of the knee.

Authors:  Alessandro De Ponti; Valerio Sansone; Marco Malcherè
Journal:  Arthroscopy       Date:  2003 Jul-Aug       Impact factor: 4.772

2.  Localized nodular pigmented villonodular synovitis of the upper ankle joint--diagnosis and treatment.

Authors:  B Ganse; P Behrens; J Gellissen; S Krüger; J P Benthien
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

3.  Surgical outcomes after excision of pigmented villonodular synovitis localized to the ankle and hindfoot without adjuvant therapy.

Authors:  Ki-Sun Sung; Kyung Rae Ko
Journal:  J Foot Ankle Surg       Date:  2015-01-21       Impact factor: 1.286

4.  Osteochondritis dissecans of the posterior femoral condyle.

Authors:  R E Outerbridge
Journal:  Clin Orthop Relat Res       Date:  1983-05       Impact factor: 4.176

5.  Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review.

Authors:  B W Myers; A T Masi
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

6.  Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?

Authors:  Matthew W Colman; Jason Ye; Kurt R Weiss; Mark A Goodman; Richard L McGough
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

7.  Clinical and oncological outcomes after surgical excision of pigmented villonodular synovitis at the foot and ankle.

Authors:  M T Korim; D R Clarke; P E Allen; C J Richards; R U Ashford
Journal:  Foot Ankle Surg       Date:  2014-02-15       Impact factor: 2.705

8.  Osteochondral destruction in pigmented villonodular synovitis during the clinical course.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Hiroatsu Nakashima; Hideshi Sugiura; Yoshihisa Yamada; Hiroshi Urakawa; Eisuke Arai; Naoki Ishiguro
Journal:  J Rheumatol       Date:  2011-12-15       Impact factor: 4.666

9.  Simultaneous anterior and posterior synovectomies for treating diffuse pigmented villonodular synovitis.

Authors:  Wei-Ming Chen; Po-Kuei Wu; Chien-Lin Liu
Journal:  Clin Orthop Relat Res       Date:  2012-02-23       Impact factor: 4.176

10.  Surgical treatment of diffuse pigmented villonodular synovitis of the knee.

Authors:  F C Flandry; J C Hughston; K E Jacobson; R L Barrack; S B McCann; D M Kurtz
Journal:  Clin Orthop Relat Res       Date:  1994-03       Impact factor: 4.176

View more
  5 in total

1.  Pigmented Villonodular Synovitis of Flexor Hallusis Longus, Flexor Digitorum Longus, Tibialis Posterior: A Rare Case Report.

Authors:  Rajesh Rana; Sudarsan Behera; Chekuri Jeetendra
Journal:  Cureus       Date:  2022-04-29

2.  Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis.

Authors:  M Siegel; L Bode; N Südkamp; J Kühle; J Zwingmann; H Schmal; G W Herget
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

3.  Gene Expression Profiles Analyzed Using Integrating RNA Sequencing, and Microarray Reveals Increased Inflammatory Response, Proliferation, and Osteoclastogenesis in Pigmented Villonodular Synovitis.

Authors:  Yang Zhao; Jiaoyun Lv; Hongwei Zhang; Jiawei Xie; Hui Dai; Xin Zhang
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

Review 4.  Recurrence of pigmented villonodular synovitis of the knee: A case report with review of literature on the risk factors causing recurrence.

Authors:  Yushun Fang; Qingsong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

Review 5.  Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations.

Authors:  Anna Vaynrub; John H Healey; William Tap; Max Vaynrub
Journal:  Onco Targets Ther       Date:  2022-01-13       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.